Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MPH Health Care AG's revenue for the
six
months ended in Dec. 2025 was €3.56 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €3.56 Mil.
MPH Health Care AG's Revenue per Share for the
six
months ended in Dec. 2025 was €0.83.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.83.
Warning Sign:
MPH Health Care AG revenue per share has been in decline over the past 3 years.
During the past 13 years, MPH Health Care AG's highest 3-Year average Revenue per Share Growth Rate was 388.50% per year. The lowest was -94.30% per year. And the median was 5.95% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
MPH Health Care AG Revenue Related Terms
MPH Health Care AG Revenue Historical Data
* Premium members only.
The historical data trend for MPH Health Care AG's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, MPH Health Care AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MPH Health Care AG Revenue vs Asset Management Industry
For the Asset Management industry and Financial Services sector, MPH Health Care AG's Revenue distribution charts can be found below:
* The bar in red indicates where MPH Health Care AG's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MPH Health Care AG (FRA:93M1) has a Revenue of €3.56 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on MPH Health Care AG and its competitors.
Is MPH Health Care AG's Revenue too high?
MPH Health Care AG's current Revenue is €3.56 Mil. Overall, MPH Health Care AG has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MPH Health Care AG's Revenue compare to BLK and BX?
MPH Health Care AG's Revenue of €3.56 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for an Asset Management company?
A good Revenue depends on the Asset Management industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on MPH Health Care AG and its competitors. MPH Health Care AG's current Revenue is €3.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPH Health Care AG stock overvalued right now?
Based on GuruFocus' analysis, MPH Health Care AG (FRA:93M1) is currently considered Significantly Overvalued. The stock's GF Value™ is €10.02, compared to a current price of €23.60 — trading 135.5% above its estimated fair value. The current Revenue is €3.56 Mil. MPH Health Care AG's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For MPH Health Care AG (FRA:93M1), the current Revenue is €3.56 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MPH Health Care AG (FRA:93M1) Overvalued in 2026?
Based on GuruFocus' analysis, MPH Health Care AG stock appears to be overvalued.
The current stock price of €23.60 is trading 135.5% above its estimated GF Value™ of €10.02.
GuruFocus considers MPH Health Care AG to be Significantly Overvalued.
Key valuation signals for FRA:93M1:
Revenue: €3.56 Mil
GF Value™: €10.02 vs. price of €23.60 (135.5% above fair value)
No single metric tells the full story. See the FRA:93M1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MPH Health Care AG is an investment company. Its business activities consist of investing in companies with the goal of capital appreciation. The strategic focus of its activities is on the acquisition and development of companies and company shares, particularly in growth segments of the healthcare market and the pharmaceutical industry.
63GF Score
Get the complete analysis for FRA:93M1
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:93M1 has been successfully added to your 
